Redwood Pharma Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Martin Olov Vidaeus, was filed 16 Nov 2021.
Redwood Pharma: what insiders have been doing
Redwood Pharma is a listed company. Its directors and officers file their transactions with Finansinspektionen. Nothing new has been filed by managers of Redwood Pharma in twelve months, the latest record being from 3 September 2023.
Our records for Redwood Pharma go back to 2017, with 5 purchases and 1 sale on the open market in total.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
- 1,800,000 sharesTeckningsrätt/UniträttISIN SE0020678605FI:csv-d426f6a3b59f929d8366
- 10,000 shares@ SEK 2.6042.3% of flowAktieISIN SE0008294789FI:csv-8ebe1e34d67ece795605Canonical exit: 14 Feb 2022 (T+90)
- 3,000 shares@ SEK 5.6627.0% of flowAktieISIN SE0008294789FI:csv-dc1d136a43476988d117Canonical exit: 17 Oct 2021 (T+90)
- 2,000 shares@ SEK 10.28100.0% of flowAktieISIN SE0008294789FI:csv-56d498362fb34bb42420Canonical exit: 16 Jun 2020 (T+90)
- 12,600 shares@ SEK 6.750.0% of flowISIN SE0008294789FI:csv-f56b5d5b33ee5ad1eab2Canonical exit: 24 Jul 2018 (T+90)
- 22,400 shares@ SEK 73,920.00100.0% of flowISIN SE0008294789FI:csv-9d6a454b72239a43a026Canonical exit: 18 Sept 2017 (T+90)
6 of 6 declarations
About Redwood Pharma
Redwood Pharma is a company focused on developing innovative ophthalmic treatments. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations